New Fight Against Cancer: Big Pharma Joins AI
A major drug company and an AI firm team up with a one billion dollar plan to find new ways to fight cancer.
Big news comes from the world of medicine. Boehringer Ingelheim, a large drug company, is teaming up with Envisagenics. Envisagenics is a company that uses AI to find new drugs. They have a big plan to find new targets for cancer drugs. This partnership could be worth up to one billion dollars.
Boehringer Ingelheim will check these new cancer targets. Envisagenics will use its smart AI technology. This tech helps find special parts of cancer cells. Finding these parts helps scientists create better medicines.
This deal means new hope for cancer patients. Companies are using smart tools to make breakthroughs. This work can lead to new treatments sooner. It shows how technology helps us in the fight against serious diseases.
Source: FierceBiotech
More from Biotech
